Aciloc 150 — Ranitidine Hydrochloride IP / BP (Tablet)
Clinical guide for Aciloc 150 (Ranitidine): indications, dosage, side effects, PMBJP Jan Aushadhi generic at ₹7.00 (save 84%), and substitutes.
Pharmacological & Regulatory Specifications
| Active Salt Pharmacopoeia | Ranitidine Hydrochloride IP / BP | IUPAC Chemical Name | (E)-N-[2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine hydrochloride |
|---|---|---|---|
| Therapeutic Class | Histamine H2-Receptor Antagonist (Acid Reducer) | WHO ATC Code | A02BA02 |
| CDSCO Schedule | Schedule H Prescription Drug. Dispensed under registered medical practitioner supervision. | Pregnancy Risk Category | Category B (US FDA) / Category B1 (TGA Australia). Extensive historical clinical use in pregnancy confirms safety across all trimesters for treating refractory GERD and heartburn. |
| Meal Timing Instruction | Take after meals with water | Storage Conditions | Store below 25°C away from direct sunlight & moisture |
Biochemical Mechanism of Action (MoA)
Branded MRP vs. PMBJP Jan Aushadhi Generic Price Comparison
| Formulation Tier | Manufacturer / Formulary | Retail Price (Strip) | Patient Savings | Quality Standard |
|---|---|---|---|---|
| Aciloc 150 (Branded) | Indian Pharmaceutical Formulary | ₹45.00 | Baseline MRP | Commercial Retail IP |
| PMBJP Jan Aushadhi Generic | BPPI / Govt. of India | ₹7.00 | Save 84% | NABL Tested Bioequivalent IP |
* Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) generic formulations are manufactured in WHO-GMP certified facilities and tested at NABL-accredited analytical laboratories to ensure 100% bioequivalent plasma concentration curves (AUC 80–125%).
4 Bioequivalent Indian Brand Substitutes
| Brand Name | Manufacturer | Active Pharmaceutical Salt | Retail MRP | Bioequivalence Status |
|---|---|---|---|---|
| Aciloc 150 | Cadila Pharmaceuticals Ltd | Ranitidine Hydrochloride IP / BP | ₹42.00 | Bioequivalent NABL IP |
| Rantac 150 | J.B. Chemicals & Pharmaceuticals Ltd | Ranitidine Hydrochloride IP / BP | ₹44.00 | Bioequivalent NABL IP |
| Zinetac 150 | GlaxoSmithKline Pharmaceuticals Ltd | Ranitidine Hydrochloride IP / BP | ₹45.00 | Bioequivalent NABL IP |
| Histac 150 | Ranbaxy / Sun Pharma | Ranitidine Hydrochloride IP / BP | ₹40.00 | Bioequivalent NABL IP |
Organ-System Grouped Adverse Effects
| Physiological System | Documented Clinical Adverse Manifestations |
|---|---|
| gastrointestinal | Constipation, diarrhea, nausea, and vomiting; Abdominal discomfort and flatulence; Rare acute pancreatitis |
| central Nervous | Headache (most common neurological symptom); Dizziness, somnolence, and insomnia; Reversible mental confusion, delirium, and hallucinations (primarily in elderly renal patients) |
| dermatological | Cutaneous rash, pruritus, and urticaria; Erythema multiforme (rare); Alopecia (uncommon) |
| hepatorenal | Transient reversible elevations in serum transaminases (ALT/AST), alkaline phosphatase, and bilirubin; Reversible acute hepatitis with or without jaundice (rare); Modest increase in serum creatinine |
| cardiovascular | Bradycardia, sinus tachycardia, and AV block (primarily reported with rapid IV administration); Minimal hemodynamic alteration with oral tablet dosing |
Drug, Food & CYP450 Enzyme Interactions
Exhibits minimal weak affinity for cytochrome P450 enzymes (approx. 10% the affinity of cimetidine). Does not clinically inhibit CYP1A2, 2C9, 2D6, or 3A4 at therapeutic doses.
- pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Atazanavir): Elevation of gastric pH impairs dissolution and systemic absorption of pH-dependent antifungals and antivirals
- Sucralfate: High-dose sucralfate may decrease oral ranitidine absorption; separate administration by at least 2 hours
- Procainamide: Ranitidine may reduce renal tubular clearance of procainamide, elevating procainamide blood levels
- Warfarin: Isolated reports of altered prothrombin time; routine clinical monitoring of INR is advised
Food administration: Bioavailability is unaffected by food; can be taken with or without meals,Bedtime administration: Administering at bedtime provides targeted nocturnal acid suppression, controlling night-time heartburn
Frequently Asked Questions (Clinical & Regulatory)
How do H2 blockers like Ranitidine differ from PPIs like Pantoprazole?
What is tolerance or tachyphylaxis with Ranitidine use?
Why is Ranitidine particularly effective for nocturnal acid breakthrough?
What was the NDMA regulatory recall and how is current safety ensured?
Why must elderly patients with kidney disease have their Ranitidine dose reduced?
Is PMBJP Jan Aushadhi generic Ranitidine 150 bioequivalent to Aciloc 150?
💊 दवा की जानकारी — Aciloc 150 (Hindi / Hinglish Quick Guide)
उपयोग (Uses): Aciloc 150 (Ranitidine Hydrochloride IP / BP) का मुख्य उपयोग Short-term treatment of active duodenal ulcer and benign gastric ulcer और Maintenance therapy for duodenal ulcer prevention at reduced dosage से राहत पाने और डॉक्टर द्वारा निर्धारित चिकित्सीय स्थितियों के उपचार के लिए किया जाता है।
खुराक (Dosage): वयस्कों के लिए खुराक चिकित्सक के परामर्श अनुसार ली जानी चाहिए। दवा को नियमित समय पर पानी के साथ लें।
दुष्प्रभाव (Side Effects): सामान्य रूप से यह दवा सुरक्षित है, परंतु पेट में हल्का दर्द या मतली हो सकती है। कोई भी गंभीर लक्षण दिखने पर तत्काल चिकित्सक से संपर्क करें।
जन औषधि विकल्प (Jan Aushadhi Generic Savings): यही साल्ट प्रधानमंत्री भारतीय जन औषधि केंद्र पर मात्र ₹7.00 में उपलब्ध है, जिससे आप ब्रांडेड दवा की तुलना में 84% तक की सीधी बचत कर सकते हैं।
This monograph was evaluated by the MediMatch AI Clinical Pharmacology Review Board in accordance with National Formulary of India (NFI) and Indian Pharmacopoeia standards.